Publications
5808 Results
- Journal / Conference
- Anti-Cancer Drugs 2(3):247-250
- Year
- 1991
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8726
Evaluation of amonafide in refractory and relapsing multiple myeloma: A Southwest Oncology Group study.
- Journal / Conference
- Cancer 68(8):1694-1695
- Year
- 1991
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8741
A Southwest Oncology Group phase II trial of recombinant tumor necrosis factor in metastatic breast cancer.
- Journal / Conference
- Cancer 68(5):934-939
- Year
- 1991
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8748
Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group study.
- Journal / Conference
- Journal of Immunotherapy 10:376-378
- Year
- 1991
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8755
A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: A Southwest Oncology Group study.
- Journal / Conference
- IND 9:373-374
- Year
- 1991
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8912
Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.
- Journal / Conference
- JCO 9(9):1618-1626
- Year
- 1991
Survival determinants in extensive stage non-small cell lung cancer. The Southwest Oncology Group experience.
- Journal / Conference
- Journal of Immunotherapy 10:426-431
- Year
- 1991
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease. A summary of the Southwest Oncology Group experience.
- Journal / Conference
- Journal of Urology 145:1178-1183
- Year
- 1991
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-7990
Staging relationships and outcome in early stage testicular cancer: A report from the testicular cancer intergroup study.
- Journal / Conference
- IND 9:329-331
- Year
- 1991
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8108
Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study.
- Journal / Conference
- Blood 77(4):726-734
- Year
- 1991
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8124/25/26, SWOG-8600